1. Home
  2. LMAT vs HCM Comparison

LMAT vs HCM Comparison

Compare LMAT & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LeMaitre Vascular Inc.

LMAT

LeMaitre Vascular Inc.

N/A

Current Price

$81.65

Market Cap

2.1B

Sector

Health Care

ML Signal

N/A

Logo HUTCHMED (China) Limited

HCM

HUTCHMED (China) Limited

HOLD

Current Price

$12.06

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LMAT
HCM
Founded
1983
2000
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.3B
IPO Year
2006
2015

Fundamental Metrics

Financial Performance
Metric
LMAT
HCM
Price
$81.65
$12.06
Analyst Decision
Buy
Sell
Analyst Count
5
1
Target Price
$105.80
$13.75
AVG Volume (30 Days)
397.6K
53.7K
Earning Date
05-05-2026
03-05-2026
Dividend Yield
0.93%
N/A
EPS Growth
30.57
N/A
EPS
1.42
N/A
Revenue
$249,602,000.00
N/A
Revenue This Year
$14.21
$20.60
Revenue Next Year
$8.88
$15.62
P/E Ratio
$57.55
$5.49
Revenue Growth
13.53
N/A
52 Week Low
$78.27
$9.77
52 Week High
$118.01
$17.79

Technical Indicators

Market Signals
Indicator
LMAT
HCM
Relative Strength Index (RSI) 40.35 50.39
Support Level $78.77 $10.73
Resistance Level $88.35 $12.90
Average True Range (ATR) 1.98 0.25
MACD 0.54 -0.09
Stochastic Oscillator 53.95 24.55

Price Performance

Historical Comparison
LMAT
HCM

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.

About HCM HUTCHMED (China) Limited

HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.

Share on Social Networks: